Excess weight loss in a patient with type 2 diabetes mellitus treated with an SGLT-2 inhibitor

Endokrynol Pol. 2019;70(6):522-523. doi: 10.5603/EP.a2019.0047. Epub 2019 Nov 4.

Authors

Edyta Cichocka¹, Janusz Gumprecht²

Affiliations

¹ School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland, Department of Internal Medicine, Diabetology, and Nephrology. [email protected].
² School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland, Department of Internal Medicine, Diabetology, and Nephrology.

PMID: 31681978
DOI: 10.5603/EP.a2019.0047

No abstract available

Keywords: SGLT-2 inhibitor; diabetes; weight loss.

Publication types

Case Reports

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Humans
Male
Middle Aged
Obesity / drug therapy*
Sodium-Glucose Transporter 2 Inhibitors / adverse effects
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
Weight Loss / drug effects*

Substances

Sodium-Glucose Transporter 2 Inhibitors